RADYSI
Live / Registered — Registered (as of 12 Apr 2022)
What this means for you
Registered since 12 Apr 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79302743
- Registration number
- 6696061
- Mark type
- Stylized text
- Filed
- 14 Dec 2020
- Published for opposition
- 25 Jan 2022
- Registered
- 12 Apr 2022
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 001 — Chemicals: Chemical preparations for scientific purposes; biochemicals for in vitro and in vivo scientific use
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations and substances used for medical purposes, namely, diagnostic agents, diagnostic reagents, contrast media, and contrast agents for use in medical diagnostic imaging in the nature of magnetic resonance imaging; contrast media and contrast agents for use in in-vivo imaging; contrast media and contrast agents for use in in-vitro imaging
Owner
- Ascelia Pharma AB, SE
- Ascelia Pharma AB, SE
- Ascelia Pharma AB, SE
Prosecution history
- 06 Dec 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 20 Sept 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 26 Aug 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 26 Aug 2022 — FINAL DISPOSITION PROCESSED
- 12 Jul 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 12 Apr 2022 — REGISTERED-PRINCIPAL REGISTER
- 25 Jan 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Jan 2022 — PUBLISHED FOR OPPOSITION
- 22 Jan 2022 — NOTIFICATION PROCESSED BY IB
- 05 Jan 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 05 Jan 2022 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 05 Jan 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Dec 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Nov 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Nov 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE